Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_assertion type Assertion NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_head.
- NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_assertion description "[At follow-up, the participants were divided into 4 groups: (a) controls: participants who were normal at both baseline and follow-up (n = 33), (b) stables: participants with MCI whose Clinical Dementia Rating-Sum of Boxes (CDR-SB) score did not differ between the first and last evaluations (n = 22), (c) decliners: participants with MCI whose CDR-SB score declined between the first and last evaluations (n = 95), and (d) converters: participants who received a clinical diagnosis of Alzheimer's disease during the follow-up period (n = 47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_provenance.
- NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_assertion evidence source_evidence_literature NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_provenance.
- NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_assertion SIO_000772 17402816 NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_provenance.
- NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_assertion wasDerivedFrom befree-20140225 NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_provenance.
- NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_assertion wasGeneratedBy ECO_0000203 NP167430.RAPw5QsWI3QldVw6XjSjIxL4IBP3jksaSV1EK_5seD4P0130_provenance.